Hetero Labs Ltd V Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HETERO LABS LTD V, and what generic and branded alternatives to HETERO LABS LTD V drugs are available?
HETERO LABS LTD V has fifty-nine approved drugs.
There are three tentative approvals on HETERO LABS LTD V drugs.
Summary for Hetero Labs Ltd V
| US Patents: | 0 |
| Tradenames: | 55 |
| Ingredients: | 54 |
| NDAs: | 59 |
Drugs and US Patents for Hetero Labs Ltd V
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hetero Labs Ltd V | DONEPEZIL HYDROCHLORIDE | donepezil hydrochloride | TABLET;ORAL | 203034-002 | Jan 30, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hetero Labs Ltd V | MOXIFLOXACIN HYDROCHLORIDE | moxifloxacin hydrochloride | TABLET;ORAL | 204836-001 | Mar 2, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hetero Labs Ltd V | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 212414-002 | May 11, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hetero Labs Ltd V | FEXOFENADINE HYDROCHLORIDE ALLERGY | fexofenadine hydrochloride | TABLET;ORAL | 204097-003 | Aug 19, 2016 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
